...
机译:在BRAF(V600E)中Neoadjuvant Dabrafenib Plus Trametinib后完成手术切除术后 - 矫正甲状腺癌
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Internal Med Dept Endocrine Neoplasia &
Hormonal Disorders;
Univ Texas MD Anderson Canc Ctr Dept Thorac Head &
Neck Med Oncol Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Internal Med Dept Endocrine Neoplasia &
Hormonal Disorders;
Univ Texas MD Anderson Canc Ctr Dept Thorac Head &
Neck Med Oncol Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Dept Diagnost Imaging Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Dept Diagnost Imaging Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Dept Pathol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Div Surg Dept Head &
Neck Surg Houston TX 77230 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiat Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Div Internal Med Dept Endocrine Neoplasia &
Hormonal Disorders;
Univ Texas MD Anderson Canc Ctr Div Internal Med Dept Endocrine Neoplasia &
Hormonal Disorders;
dabrafenib; trametinib; pembrolizumab; squamous; sarcomatoid; anaplastic thyroid cancer; dedifferentiated; undifferentiated; targeted therapy; chemotherapy; surgery;
机译:在BRAF(V600E)中Neoadjuvant Dabrafenib Plus Trametinib后完成手术切除术后 - 矫正甲状腺癌
机译:Dabrafenib Plus Trametinib在BRAF V600E Anaplastic甲状腺癌中处于活跃
机译:Dabrafenib的间歇剂量给药和转移BRAF(V600E)突变乳头状甲状腺癌:两种报告
机译:从概念到诊所的机器学习:使用高尺寸RNA表达数据可靠地检测甲状腺结节中的BRAF V600E DNA突变
机译:用于治疗BRAF V600E突变父母和vemureafenib抗性黑素瘤的纳米脂质体的研制
机译:在BRAFV600E突变型间变性甲状腺癌中新辅助治疗的Dabrafenib加Trametinib术后的完整手术切除
机译:疗效和循环肿瘤DNA(CTDNA)分析BRAF抑制剂DABRAFENIB(D),MEK抑制剂TRAMETINIB(T),患者(PTS)中的抗EGFR抗体Panitumumab(P),BRAF V600E突变(BRAFM)转移性结直肠癌(MCRC)